Vanguard Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.29B Buy
52,275,767
+267,058
+0.5% +$20.8M 0.06% 284
2025
Q3
$3.91B Sell
52,008,709
-99,049
-0.2% -$7.39M 0.06% 307
2025
Q2
$3.86B Buy
52,107,758
+703,903
+1% +$49M 0.06% 301
2025
Q1
$4.15B Sell
51,403,855
-1,133,591
-2% -$97.4M 0.08% 261
2024
Q4
$4.11B Buy
52,537,446
+2,155,429
+4% +$183M 0.07% 268
2024
Q3
$4.73B Buy
50,382,017
+1,390,520
+3% +$117M 0.08% 225
2024
Q2
$3.82B Buy
48,991,497
+472,157
+1% +$38.5M 0.07% 270
2024
Q1
$4.41B Buy
48,519,340
+4,107,746
+9% +$342M 0.09% 225
2023
Q4
$3.43B Sell
44,411,594
-119,808
-0.3% -$8.39M 0.08% 273
2023
Q3
$3.03B Buy
44,531,402
+5,693,244
+15% +$414M 0.07% 266
2023
Q2
$3.16B Buy
38,838,158
+2,802,577
+8% +$224M 0.07% 277
2023
Q1
$2.96B Buy
+36,035,581
New +$2.57B 0.08% 285

Other funds holding GEHC

Vanguard Group's GEHC Position: Q4 2025 in Review

Vanguard Group increased its GE HealthCare (GEHC) stake by 0.51% in Q4 2025, buying an estimated $20.8M and bringing the position to 52,275,767 shares worth $4.29B. The position accounts for 0.06% of the portfolio, ranked #284.

Vanguard Group first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $4.73B in Q3 2024. 1,335 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Vanguard Group held 52,275,767 shares of GE HealthCare worth $4.29B as of Q4 2025.
  • Vanguard Group bought 267,058 GE HealthCare shares in Q4 2025, an estimated $20.8M.
  • GE HealthCare made up 0.06% of Vanguard Group's portfolio in Q4 2025, its #284 holding.
  • Vanguard Group first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • Vanguard Group's GE HealthCare position peaked at $4.73B in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.